Specifications tableSubject area*Biology*More specific subject area*Genomics, bioinformatics*Type of data*Table, figure*How data was acquired*Microarray data repository: Gene Expression Omnibus (GEO) provided by the National Center for Biotechnology Information (NCBI) and Array Express provided by the European Bioinformatics Institute (EBI)*Data format*Raw data*Experimental factors*Database search, dataset selection, TRAM (Transcriptome Mapper) analysis*Experimental features*Analysis of gene expression data by TRAM software; enrichment function analysis*Data source location*Data sources are public database entries and are listed in the*[Supplementary Table 1](#appsec1){ref-type="sec"}*Meta-analysis results have been obtained in Bologna, Italy, DIMES Department at University of Bologna*Data accessibility*Data are with this article*Related research article[@bib1]**Value of the data**•The meta-analysis performed in this study provides a differential reference expression value for 24,699 known, mapped transcripts, common to total and histologically normal thyroid adjacent to papillary thyroid carcinoma, and a view of the genomic regions with altered expression by a chromosomal segment representation.•The histologically normal thyroid adjacent to papillary thyroid carcinoma is often used as normal control in thyroid tumor studies. Differentially expressed genes identified in this comparison provide a molecular view of the behavior of normal tissue adjacent to papillary thyroid carcinoma vs. total normal thyroid tissue and might yield biological insight about the biology of thyroid tumors.•Enrichment function analysis performed for the gene groups classified on their gene expression ratio intervals identified interesting molecular functions of genes which are under-expressed in total normal thyroid and on the contrary have a high expression level in the normal thyroid adjacent to papillary thyroid carcinoma.•The housekeeping gene search useful for gene expression studies on thyroid tissue retrieved 414 loci, different from those retrieved in the total normal thyroid except for seven genes as *ACTG1*, *BLOC1S2*, *DIABLO*, *OCIAD2*, *GTPBP6*, *EIF2B2*, *AKR1B1*.•The quantitative reference values of the enzyme mRNAs might be used in metabolic network models for the validation of hypotheses about the relationships among mRNA levels, corresponding enzymatic proteins and the quantities of their substrates or products obtained by metabolome experiments.

1. Data {#sec1}
=======

1.1. Database searching and database building {#sec1.1}
---------------------------------------------

The systematic search performed in gene expression data repositories retrieved 35 datasets from 10 microarray experiments on the total normal human thyroid and 40 datasets from 4 microarray experiments on the histologically normal thyroid adjacent to papillary thyroid carcinoma. The 35 datasets of the total thyroid were already used in Ref. [@bib1]. Sample identifiers (GEO and EBI ID numbers) and main sample features are listed in the [Supplementary Table 1](#appsec1){ref-type="sec"}.

1.2. Total normal thyroid vs. histologically normal thyroid adjacent to papillary thyroid carcinoma transcriptome map {#sec1.2}
---------------------------------------------------------------------------------------------------------------------

The differential transcriptome map was performed integrating 35 datasets from total normal human thyroid [@bib1] and 40 datasets from histologically normal thyroid adjacent to papillary thyroid carcinoma. The 35 datasets included in the Pool A folder provided reference gene expression values for 25,574 loci coming from 947,816 data points (data from Ref. [@bib1] updated after the analysis with TRAM 1.3 software version), the 40 datasets included in the Pool B folder provided reference gene expression values for 24,699 loci ([Supplementary Table 2](#appsec1){ref-type="sec"}) coming from 1,917,840 data points, and the differential transcriptome map obtained provided reference gene expression values for 24,699 loci ([Supplementary Table 3](#appsec1){ref-type="sec"}) common to both pools ([Fig. 1](#fig1){ref-type="fig"}).Fig. 1**Meta-analysis study design**. A search for thyroid tissue gene expression profiles was performed on the online databases GEO and Array Express. It was followed by the selection of experiments and samples according to the inclusion and exclusion criteria, the import and elaboration of data by TRAM software, and the generation and analysis of the whole normal thyroid, histologically normal thyroid adjacent to papillary thyroid carcinoma as well as of the whole normal thyroid vs. histologically normal thyroid adjacent to papillary thyroid carcinoma transcriptome maps. PTC: papillary thyroid carcinoma.Fig. 1

At single gene level, the known gene *HTN3*, encoding for histatin 3, has the highest gene expression ratio (360.91) followed by *STATH*, encoding for statherin (gene expression ratio=324.27), *HTN1*, encoding for histatin 1 (gene expression ratio=240.67), *SMR3B* encoding for submaxillary gland androgen regulated protein 3B (gene expression ratio=128.73) and *ZG16B* encoding for zymogen granule protein 16B (gene expression ratio=116.25) ([Table 1](#tbl1){ref-type="table"}). These 5 genes are over-expressed in total normal thyroid and have a very low expression value in the histologically normal thyroid adjacent to papillary thyroid carcinoma ([Table 1](#tbl1){ref-type="table"}). Fifty genes have a gene expression ratio between 10 and 100 ([Table 1](#tbl1){ref-type="table"}).Table 1List of loci of the differential transcriptome map between whole normal thyroid (Pool A) and histologically normal thyroid adjacent to papillary thyroid carcinoma (Pool B). Loci are sorted in descending order of expression ratio (Ratio A/B). Chr: chromosome. SD: standard deviation. N/A: not available in the "NCBI Gene" database (<http://www.ncbi.nlm.nih.gov/gene>) when the analysis was performed.Table 1Gene nameChrLocationValue AValue BRatio A/BData Points AData Points BSD as % of Expression ASD as % of Expression BGene expression ratio \>100*HTN3*chr44q13.31,876.985.20360.912540130.0210.20*STATH*chr44q13.32,224.346.86324.273340150.2830.81*HTN1*chr44q13.32,039.628.47240.673140155.5348.36*SMR3B*chr44q13.31,444.8611.22128.732840137.5156.34*ZG16B*chr1616p13.31,779.8415.31116.251640110.2058.66Gene expression ratio \>10 and \<100*LINC01521*chr2222q12.21,034.9111.4290.651540260.8977.62*PTH*chr1111p15.3343.995.1067.453840126.9324.13*MUC7*chr44q13.3495.478.5857.725380260.3154.80*NACA2*chr1717q23.2544.389.8055.532940143.0279.12*PRH1*chr1212p13.21,346.4026.1451.514080183.5877.46*HBD*chr1111p15.41,016.6521.4847.334940210.9754.06*SMR3A*chr44q13.3318.577.8640.534080220.1033.07*KRT13*chr1717q21.2332.619.5434.863040478.3540.15*LINC01234*chr1212q24.13214.176.5232.852480325.5031.97*CST4*chr2020p11.21791.1631.2025.352140191.6029.20*FOXM1*chr1212p13.33291.0013.3321.823340395.2129.83*CST1*chr2020p11.21206.189.4821.743140208.1330.56*MGC16025*chr22q37.3149.467.6319.591540245.7435.23*GBP4*chr11p22.2542.6028.0019.383980408.8959.18*TAS2R1*chr55p15.31350.2118.0719.383140408.6021.54*HCAR3*chr1212q24.31285.7915.5418.392240309.9255.06*GABRD*chr11p36.33278.2615.7217.704780475.4254.59*PPIAL4A*chr11p11.2104.496.0317.342140231.2244.18*LINC02078*chr1717q25.3170.7710.0017.081340227.5731.84*BPIFB2*chr2020q11.21290.5417.2716.822640275.5635.69Hs.649237chr16N/A393.8424.4216.13114041.6764.68*PIP*chr77q34360.8122.4816.053540187.8249.66*AKAP6*chr1414q12191.9512.6315.205180650.3048.25*RHOC*chr11p13.2180.9513.4713.442440103.2835.67*CCDC103*chr1717q21.31463.6934.9813.261340231.4120.32*CRCT1*chr11q21.392.277.0413.103140493.7029.20*SBSN*chr1919q13.12187.2714.4113.002240414.0453.84*NPHS2*chr11q25.2275.8321.3212.933140382.7163.61*KRT6A*chr1212q13.13105.188.3512.605080576.3055.43*BPIFA2*chr2020q11.21236.5418.9212.502640133.5548.56*AGXT*chr22q37.3132.6510.7512.3473120548.6744.40*CNFN*chr1919q13.2165.8113.7912.022640355.3318.49*CRISP3*chr66p12.363.555.3011.983340158.9820.82*CEP19*chr33q29277.2023.2011.954580348.4962.90*KLF8*chrXXp11.21290.0624.3511.914780473.9983.04*PLA2G1B*chr1212q24.3193.867.9911.743540153.9638.29*KIR3DX1*chr1919q13.42190.2316.5311.515380446.2861.41*PSORS1C1*chr66p21.33154.5913.4911.462340301.2222.86*KRT4*chr1212q13.13191.3716.9611.285380621.3464.17*ALPP*chr22q37.1209.5018.9311.075180467.8670.41*SPRR3*chr11q21.3155.4114.0511.065280455.1343.64*PRR4*chr1212p13.2233.8121.4210.923340169.4026.73*FOXL2*chr33q22.399.019.2510.703340211.9053.22*DMRTC2*chr1919q13.257.745.4710.562640174.3516.37*DNMT3L*chr2121q22.3101.549.6810.493140357.8928.81*POLE*chr1212q24.33328.7131.4410.464940417.3425.33*GALNT4*chr1212q21.33376.3136.3110.363680411.0174.50*MTPN*chr77q33256.9124.8810.332640127.0538.70*C9*chr55p13.149.484.8210.263340307.4914.30*GPR88*chr11p21.253.335.2510.173340249.8313.38

The genome segment that has the highest statistically significant expression value is on chromosome 4 (4q13.3) ([Table 2](#tbl2){ref-type="table"}) including the over-expressed known genes (*STATH*, *HTN1*, *HTN3, SMR3A, SMR3B, MUC7*). There are no significantly under-expressed segments.Table 2The genomic segments significantly over-expressed in the total normal thyroid (Pool A) vs. histologically normal thyroid adjacent to papillary thyroid carcinoma (Pool B) differential transcriptome map. Over-expressed genes are in bold, under-expressed genes are with an asterisk and in bold. Under-expressed genomic segments were not found.Table 2Chr and locationSegment startSegment endValue A/Bq-valueGenes in the segmentchr4 (4q13.3)70,000,00170,500,000105.520.00000017***STATH HTN3 HTN1 MR3A SMR3B MUC7***chr4 (4q13.3)70,250,00170,750,00021.340.00201816***SMR3A SMR3B MUC7 UTP3\****chr12 (12p13.2)11,000,00111,500,0009.310.00214630***PRH1 PRB3 PRB4***chr20 (20p11.21)23,500,00124,000,0006.990.00000413***CST3 CST4 CST1 CST2 CST5***chr12 (12p13.2)10,750,00111,250,0006.050.00335694***TAS2R10 PRR4 PRH1***chr16 (16q23.1-q23.2)78,500,00179,000,0004.500.00024953**Hs.649237 Hs.648714 Hs.649874**chr17 (17q21.2)41,250,00141,750,0003.610.00021980***KRT31 KRT35 KRT13 KRT15 KRT14***chr1 (1q21.3)152,250,001152,750,0003.440.00113717***CRNN CRCT1 LCE2B***chr1 (1q21.3)153,000,001153,500,0003.150.00004193***SPRR3 SPRR1B PGLYRP3 S100A9 S100A12***chrX (Xq13.2)74,000,00174,500,0002.880.00011566**Hs.720466 *FTX* Hs.607917 Hs.625698**chr17 (17q21.2)41,000,00141,500,0002.510.00003900***KRTAP1-5 KRTAP4-6 KRTAP4-4 KRTAP4-1 KRTAP9-3 KRT31 KRT35***chr17 (17q12.2)40,750,00141,250,0002.510.00016288***KRTAP3-2 KRTAP1-5 KRTAP4-6 KRTAP4-4 KRTAP4-1 KRTAP9-3***chr11 (11q14.1)85,750,00186,250,0002.150.00045054**Hs.658368 Hs.658335 Hs.656225**chr19 (19q13.33)49,750,00150,250,0001.980.01225630***AKT1S1 TBC1D17 ATF5***

1.3. Functional enrichment analysis {#sec1.3}
-----------------------------------

The results of functional enrichment analysis, performed by "ToppFun" from the "ToppGene Suite" Gene Ontology tool, of over- and under-expressed genes (with expression ratios between 1.30 and 10.00 and 0.69 and 0, respectively) in the total normal thyroid vs. histologically normal thyroid adjacent to papillary thyroid carcinoma differential transcriptome map, are shown in [Table 3](#tbl3){ref-type="table"} and [Table 4](#tbl4){ref-type="table"}. Input gene lists included 5,012 out of 6,686 over-expressed and 4,258 out of 4,854 under-expressed genes resulted following exclusion of all the EST clusters ([Supplementary Table 3](#appsec1){ref-type="sec"}).Table 3Results of functional enrichment analysis, performed by "ToppFun" from the "ToppGene Suite" Gene Ontology tool, of over-expressed genes (with expression ratios between 1.30 and 10.00) in the total normal thyroid vs. histologically normal thyroid adjacent to papillary thyroid carcinoma differential transcriptome map. The first 10 results of each Gene Ontology categories are listed. Complete results are provided in [Supplementary Table 4](#appsec1){ref-type="sec"}.Table 3Gene expression ratio 1.30--10.00Genes from inputGO: molecular functionNamep-Value148GO:0022838substrate-specific channel activity5.76E-09143GO:0005216ion channel activity1.19E-08155GO:0022803passive transmembrane transporter activity1.91E-08154GO:0015267channel activity2.92E-08294GO:0022857transmembrane transporter activity4.18E-08114GO:0022836gated channel activity1.02E-07256GO:0015075ion transmembrane transporter activity1.15E-0714GO:0005132type I interferon receptor binding2.04E-07358GO:0005215transporter activity3.17E-0758GO:0022834ligand-gated channel activity1.52E-06Genes from inputGO: Biological processNamep-Value15GO:0033141positive regulation of peptidyl-serine phosphorylation of STAT protein1.82E-06432GO:0006811ion transport2.85E-0615GO:0033139regulation of peptidyl-serine phosphorylation of STAT protein4.55E-0619GO:0002323natural killer cell activation involved in immune response9.71E-0638GO:0060349bone morphogenesis2.38E-0522GO:0003009skeletal muscle contraction2.51E-0516GO:0042501serine phosphorylation of STAT protein3.03E-0521GO:0033275actin-myosin filament sliding3.74E-05Genes from inputGO: Cellular componentNamep-Value422GO:0005615extracellular space1.14E-11472GO:0031226intrinsic component of plasma membrane4.23E-09453GO:0005887integral component of plasma membrane1.49E-08297GO:0098590plasma membrane region1.36E-0779GO:0045211postsynaptic membrane3.42E-0697GO:0097060synaptic membrane1.19E-05339GO:0098589membrane region1.26E-0591GO:0034702ion channel complex1.15E-0499GO:1902495transmembrane transporter complex2.26E-04128GO:0031012extracellular matrix3.14E-04Table 4Results of functional enrichment analysis, performed by "ToppFun" from the "ToppGene Suite" Gene Ontology tool, of under-expressed genes (with expression ratios between 0 and 0.69) in the total normal thyroid vs. histologically normal thyroid adjacent to papillary thyroid carcinoma differential transcriptome map.Table 4Gene expression ratio 0.69--0Genes from inputGO: molecular functionNamep-Value463GO:0003723RNA binding8.64E-16499GO:0019899enzyme binding8.25E-10467GO:0035639purine ribonucleoside triphosphate binding6.77E-09472GO:0001882nucleoside binding7.30E-09480GO:0017076purine nucleotide binding1.13E-08469GO:0001883purine nucleoside binding1.17E-08469GO:0032549ribonucleoside binding1.17E-08468GO:0032550purine ribonucleoside binding1.31E-08475GO:0032555purine ribonucleotide binding1.91E-08478GO:0032553ribonucleotide binding2.33E-08Genes from inputGO: Biological processNamep-Value274GO:0032446protein modification by small protein conjugation6.27E-13294GO:0070647protein modification by small protein conjugation or removal1.24E-10233GO:0016567protein ubiquitination2.16E-10478GO:0065003protein-containing complex assembly5.47E-1038GO:1904667negative regulation of ubiquitin protein ligase activity2.40E-09264GO:1903047mitotic cell cycle process3.45E-09284GO:0000278mitotic cell cycle4.09E-0939GO:0031145anaphase-promoting complex-dependent catabolic process4.13E-09259GO:0006396RNA processing4.70E-09163GO:0044772mitotic cell cycle phase transition1.06E-08Genes from inputGO: cellular componentNamep-Value483GO:0005739mitochondrion4.47E-14270GO:0005730nucleolus2.18E-13225GO:1990904ribonucleoprotein complex3.42E-11116GO:0016604nuclear body9.51E-08261GO:0044429mitochondrial part8.96E-0716GO:0022624proteasome accessory complex1.08E-0650GO:0000784nuclear chromosome, telomeric region2.84E-06220GO:0005768endosome3.85E-06310GO:0005773vacuole4.78E-0610GO:0008540proteasome regulatory particle, base subcomplex5.08E-06

1.4. Housekeeping gene search {#sec1.4}
-----------------------------

In the histologically normal thyroid adjacent to papillary thyroid carcinoma transcriptome map, the search for housekeeping genes with the described criteria ([Methods section](#sec2){ref-type="sec"}) retrieved 414 loci, including the known genes *RPL41*, and *TG*, encoding for ribosomal protein L41 and thyroglobulin, respectively, having low standard deviation (SD), the highest expression values and a high number of data points (n=40) ([Table 5](#tbl5){ref-type="table"}). This search did not give the same results of total normal thyroid transcriptome map (see [Table 4](#tbl4){ref-type="table"} [@bib1]). The two transcriptome maps have in common only seven genes: *ACTG1*, *BLOC1S2*, *DIABLO*, *OCIAD2*, *GTPBP6*, *EIF2B2*, *AKR1B1*.Table 5List of the first 20 (out of 414) predicted housekeeping genes for the histologically normal thyroid adjacent to papillary thyroid carcinoma transcriptome map.Table 5Gene nameChromosomeLocationExpression value BData points BSD as % of expression B***RPL41***chr1212q13.27,559.25407.67*RPL39*chrXXq244,195.49408.47*RPL9*chr44p144,586.084010.91***TG***chr88q24.227,619.574011.06*ACTG1*chr1717q25.33,836.408011.55*RPL27*chr1717q21.312,928.504013.95*TOMM6*chr66p21.1368.694014.09*WASHC5*chr88q24.13118.484014.34*RRAGA*chr99p22.1594.554014.51*NDUFA4*chr77p21.31,563.684014.70*PTDSS1*chr88q22.1493.864014.98*RPS13*chr1111p15.12,900.714015.08*KIAA1191*chr55q35.2496.474015.33*CTR9*chr1111p15.4254.234015.58*DUSP11*chr22p13.1180.364015.78*RPS4X*chrXXq13.14,512.678016.15*SLTM*chr1515q22.1558.064016.18*MRPS35*chr1212p11.22275.884016.37*UNC50*chr22q11.2435.554016.45*FAM96A*chr1515q22.31499.934016.80[^1]

2. Experimental design, materials and methods {#sec2}
=============================================

2.1. Database search and selection {#sec2.1}
----------------------------------

Gene expression data repositories were systematically searched for any single human thyroid sample available from subjects explicitly stated as "healthy" or "normal" as previously described [@bib1]. The criteria for inclusion or exclusion in the analysis of each retrieved dataset were as previously described [@bib2]. In addition, datasets from histologically normal thyroid adjacent to papillary thyroid carcinoma were collected when available in the experiments retrieved as described.

2.2. TRAM analysis {#sec2.2}
------------------

TRAM software [@bib3] allows the import, decoding of probe set identifiers to gene symbols via UniGene data parsing [@bib4], integration and normalization of gene expression data recorded in the GEO and ArrayExpress databases or in a custom source in tab-delimited text format for the generation and analysis of transcriptome maps [@bib1], [@bib5]. Furthermore, it creates a graphical representation of gene expression profiles along the chromosomes and determines the statistical significance of differential expression of chromosomal segments through hypergeometric distribution [@bib3], [@bib6].

The most current version of TRAM has been used (TRAM 1.3, set up on November 11, 2017) [@bib5]. Pool A was composed of whole normal thyroid tissue datasets, while Pool B included histologically normal thyroid adjacent to papillary thyroid carcinoma datasets ([Supplementary Table 1](#appsec1){ref-type="sec"}), thus allowing the creation of a differential expression map between the two biological conditions along with the maps for each separate condition. Thresholding of sample expression values equal to or lower than "0" (≤0) [@bib2], calculation of the mean expression value for each locus and determination of percentiles of expression for each gene have been previously described [@bib2], [@bib3].

The parameters for the "Map" mode graphical representation were chosen based on the gene distribution in human genome [@bib7], [@bib8] (window size of 500,000 base pairs or bp and a shift of 250,000 bp). For each segment, its expression value, the over-/under-expression and the statistical significance have been calculated by TRAM as described [@bib3], [@bib5].

Apart from gene expression analyses, these data might be used in metabolic network models [@bib9], [@bib10], [@bib11], [@bib12] for the validation of hypotheses about the relationships among mRNA levels, corresponding enzymatic proteins and the quantities of their substrates or products obtained by metabolome experiments [@bib13], [@bib14].

The data related to the human normal whole thyroid have already been experimentally validated by "Real-Time" reverse transcription polymerase chain reaction obtaining an excellent correlation coefficient (r=0.93) between *in vitro* and *in silico* data as previously described [@bib1].

It was not possible to validate the data related to histologically normal thyroid gland adjacent to papillary thyroid carcinoma because commercial RNA of this particular type of tissue is not available, however experimental validations of the results obtained in several previous studies [@bib1], [@bib2] show that the results provided by the TRAM tool were highly reliable [@bib15].

2.3. Functional enrichment analysis {#sec2.3}
-----------------------------------

An enrichment function analysis was performed for three arbitrarily chosen intervals of ratio of the mean gene expression values: expression ratio close to one (0.70--1.29) implying that the genes are not differentially expressed between histologically normal thyroid adjacent to papillary thyroid carcinoma and total thyroid, expression ratio ≥1.30 (1.30--10.00) and expression ratio \<0.7 (0.69--0). The first interval includes 13,104 loci, the second 6,686, the third 4,854, respectively ([Supplementary Table 3](#appsec1){ref-type="sec"}). The analysis was performed using "ToppFun" from the "ToppGene Suite" Gene Ontology tool [@bib16]. We submitted the list of genes with expression ratio ≥1.30 and a list of genes of all the chromosomes with expression ratio \<0.7, excluding EST clusters. The selected genes were categorized according to GO classification based on their hypothetical molecular functions and biological processes. The analysis was assessed for Molecular Function and Biological Process and Cellular Component categories.

2.4. Housekeeping gene search {#sec2.4}
-----------------------------

A search of housekeeping genes best suitable for the study of histologically normal thyroid adjacent to papillary thyroid carcinoma (Pool B) has been performed using an optimal combination of parameters [@bib15], [@bib17]: in this case, expression value \>100, number of data points ≥20 and SD, expressed as a percentage of the mean value, ≤30.

Transparency document {#appsec1}
=====================
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[^1]: Genes are sorted in ascending order of SD as percentage of the mean value. In bold, the two best genes at behaving like housekeeping genes due to a combination of a low SD, a high expression value and a high number of data points. Following checking in the "Values B" TRAM table, the 40 (*TG*), and the 40 (*RPLP41*) data points are derived from all the 40 samples of the histologically normal thyroid adjacent to papillary thyroid carcinoma dataset analyzed.
